Ionis Announces Submission of Marketing Authorization Application for Inotersen to the EMA Post author:Sam Post published:November 2, 2017 Post category:BioPharma The MAA will be reviewed under the EMA’s Accelerated Assessment program. Source: BioSpace You Might Also Like University Enterprise Laboratories Announces Partnership With (UMGC) July 13, 2017 Outrage Leads Senator to Draft Bill in Response to Allergan's 'Should-be-Illegal' Patent Maneuver October 5, 2017 Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016 March 26, 2017
Outrage Leads Senator to Draft Bill in Response to Allergan's 'Should-be-Illegal' Patent Maneuver October 5, 2017
Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016 March 26, 2017
